ReviewCurrent medicinal chemistry2026
Research Progress on the Application of Ultrasound Assistance in Tumor Immunotherapy.
Review in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Advances in porphyrin-based photosensitizers for photodynamic therapy of A549 lung cancer.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, ultrasound (US)-assisted tumor immunotherapy has attracted widespread attention due to its deep penetration as well as its non-invasive and non-ionizing radiation properties. In this review, we briefly elucidated the mechanisms of anti-tumor immunotherapy assisted by the US. The contents include the following: the mechanical effects, thermal effects, and cavitation effects of US, sonodynamic therapy, US combined with programmed cell death protein 1 / programmed cell death 1 ligand 1 antibodies, US-enhanced chimeric antigen receptor T cell immunotherapy, cell pyroptosis and US, US combined with radiotherapy, US combined with glycolysis inhibition, and the use of various US-modulated signaling pathways to enhance tumor immunity. This review provides a broad overview of the mechanisms and roles of US assistance in tumor immunotherapy.
Indexed as
Identifiers
41208064What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.